Tradestie Institutional Equity Comparison Engine
LAFAR vs ABEO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABEO Overall Edge
ABEO Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, LAFAR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ABEO at 18.7x Forward P/E and -186.1% operating margin (+2745.0% YoY). In options structure, LAFAR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ABEO
LAFAR N/M vs ABEO 18.7x Fwd P/E
Growth & Margin Winner
ABEO
Op Margin N/A vs -186.1% ยท YoY N/A vs +2745.0%
Momentum & Technical Winner
ABEO
1Y -59.8% vs -42.4% ยท 52W Pos 0% vs 6%
Options & Structure Winner
ABEO
UNCLASSIFIED (N/A IV) vs BREAKDOWN (27th %ile IV)
LAFAR
US Equity
LAFAR
Institutional Equity
$0.06
-7.23% 1D
Market Cap
N/A
1M Return
-44.27%
1Y Return
-59.8%
Forward P/E
N/M
Unified AI Score
47.9 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
ABEO
NASDAQ
Abeona Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.42
-1.22% 1D
Market Cap
$167.4M
1M Return
-45.86%
1Y Return
-42.38%
Forward P/E
18.7x
Unified AI Score
49.9 / 100
HOLD
Tech 60.0
Fund 61.0
Flow 67.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
LAFAR -59.8%
ABEO -42.38%
Spread: +6.79 pp (ABEO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
LAFAR TTM Op. Margin: N/A
ABEO TTM Op. Margin: -186.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LAFAR vs ABEO. Trailing 12-month operating profitability (LAFAR N/A vs ABEO -186.1%) and valuation multiples (LAFAR N/M vs ABEO 18.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LAFAR | ABEO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $167.4M | Larger Scale | ABEO |
| Trailing P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Forward P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Revenue Growth (YoY) Growth | N/A | +2745.0% | Higher Growth | ABEO |
| Operating Margin (TTM) Profitability | N/A | -186.1% | Higher Margin | ABEO |
| Net Profit Margin Profitability | N/A | -160.3% | Higher Margin | ABEO |
| Return on Equity (ROE) Capital Efficiency | N/A | -42.1% | Higher ROE | ABEO |
| 52-Week Range Position Momentum | 0% ($0โ$0) | 6% ($2โ$8) | Stronger Trend | ABEO |
| Beta / 30D Volatility Risk Regime | 0.32ฮฒ ยท 187% Vol | 0.60ฮฒ ยท 149% Vol | Lower Realized Risk | ABEO |
| Unified Institutional Score Composite Signal | 47.9 / 100 (HOLD) | 49.9 / 100 (HOLD) | Higher Composite | ABEO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full LAFAR vs ABEO Buy Guide
LAFAR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ABEO
BREAKDOWN
71d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
27th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither LAFAR nor ABEO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.